Li XK et al. |
FTY720, a novel immunosuppressive agent, enhances upregulation of the cell adhesion molecular ICAM-1 in TNF-alpha treated human umbilical vein endothelial cells. |
|
Transplant. Proc. |
pmid:9123298
|
Zhang Z et al. |
FTY720 attenuates accumulation of EMAP-II+ and MHC-II+ monocytes in early lesions of rat traumatic brain injury. |
|
J. Cell. Mol. Med. |
pmid:17488479
|
Ubai T et al. |
FTY720 induced Bcl-associated and Fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft. |
|
Anticancer Res. |
pmid:17352219
|
Kahan BD |
FTY720: a new dimension in transplantation. |
|
Transplant. Proc. |
pmid:11750324
|
Brinkmann V et al. |
FTY720: dissection of membrane receptor-operated, stereospecific effects on cell migration from receptor-independent antiproliferative and apoptotic effects. |
|
Transplant. Proc. |
pmid:11750323
|
Chen S et al. |
FTY720, a novel transplantation drug, modulates lymphocyte migratory responses to chemokines. |
|
Transplant. Proc. |
pmid:11750317
|
Tedesco-Silva H et al. |
FTY720 and everolimus in de novo renal transplant patients at risk for delayed graft function: results of an exploratory one-yr multicenter study. |
|
Clin Transplant |
pmid:19719728
|
Sordillo PP et al. |
Review: The Prolonged QT Interval: Role of Pro-inflammatory Cytokines, Reactive Oxygen Species and the Ceramide and Sphingosine-1 Phosphate Pathways. |
|
In Vivo |
pmid:26546519
|
Suleiman M et al. |
FTY720 prevents renal T-cell infiltration after ischemia/reperfusion injury. |
|
Transplant. Proc. |
pmid:15808648
|
Yan S et al. |
Control of intestinal allograft rejection by FTY720 and costimulation blockade. |
|
Transplant. Proc. |
pmid:15808565
|